AB0428 SAFETY AND PERSISTENCE OF TREATMENT WITH GOLIMUMAB VERSUS CERTOLIZUMAB IN RHEUMATOID ARTHRITIS: RESULTS FROM BIOBADABRASIL COHORT STUDY.

التفاصيل البيبلوغرافية
العنوان: AB0428 SAFETY AND PERSISTENCE OF TREATMENT WITH GOLIMUMAB VERSUS CERTOLIZUMAB IN RHEUMATOID ARTHRITIS: RESULTS FROM BIOBADABRASIL COHORT STUDY.
المؤلفون: Bredemeier, M., Ramos, S., Solórzano, C., Duarte, A., Pinheiro, M., Stadler, B., Macieira, J. C., Ranza, R., Miranda, J., Valim, V., Castro, G., Bertolo, M., Sauma, M. D. F., Fernandes, V., Medeiros-Ribeiro, A. C., Botelho, R., Brenol, C., Da Silveira De Carvalho, H. M., Studart, S., Da Rocha Castelar Pinheiro, G., Rocha, L., De Leon de Lima, H., Pereira, I., Ohira Gazzeta, M., Kakehasi, A., Louzada, P., Hayata, A. L. S., Pina, F., Lupo, C., Balarini, L., Silveira, I. G., Kowalski, S., Titton, D., Ranzolin, A., Xavier, R., Laurindo, I., Antonio Araujo Da Rocha Loures, M.
المصدر: Scientific Abstracts
بيانات النشر: BMJ Publishing Group Ltd and European League Against Rheumatism
سنة النشر: 2023
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/annrheumdis-2023-eular.4583
الإتاحة: https://doi.org/10.1136/annrheumdis-2023-eular.4583Test
رقم الانضمام: edsbas.80AAC8A2
قاعدة البيانات: BASE
الوصف
DOI:10.1136/annrheumdis-2023-eular.4583